Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

The features of psychopharmacotherapy of depressive states with panic attacks

Иванец Н. Н., Кинкулькина М. А., Тартынский К. М., Кренкель Г. Л.
Журнал неврологии и психиатрии им. C.C. Корсакова
Т. 118, Вып. 4, С. 65-69
Опубликовано: 2018
Тип ресурса: Статья

DOI:10.17116/jnevro20181184165-69

Аннотация:
Objective. To develop therapeutic programs for treatment of depression with panic attacks on the basis of their clinical and psychopathological features. Material and methods. A total of 100 in-and outpatients, aged from 18 to 60 years, with depression of mild and moderate severity with panic attacks were studied. The investigation was carried out using clinical, psychopathological and psychometric (the Atypical Depression Diagnostic Scale (ADDS), the Montgomery—Asberg Depression Rating Scales (MADRS), and the Sheehan Anxiety Rating Scale (ShARS)) methods. The patients were assessed on admission, on the 1st, 2nd, 4th and 8th weeks with subsequent processing and defining standard indicators. Three therapeutic groups were formed: the 1st group received therapy combining an antidepressant and a tranquilizer; the 2nd group an antidepressant, a tranquilizer and a mood stabilizer; and the 3rd group an antidepressant, a tranquilizer and an antipsychotic agent. The time course of expression of
Ключевые слова:
Antidepressants; Antipsychotics; Anxiety disorders; Bipolar affective disorder; Depression; Mood stabilizers; Neurotic depression; Panic attacks; Psychopharmacotherapy; Recurrent depressive disorder
antidepressant agent; mood stabilizer; tranquilizer; neuroleptic agent; adult; anxiety; Article; bipolar disorder; controlled study; depression; Hamilton Anxiety Scale; human; major clinical study; Montgomery Asberg Depression Rating Scale; panic; psychopharmacotherapy; adolescent; middle aged; psychological rating scale; young adult; Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Humans; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Young Adult
Язык текста: Русский
ISSN: 2309-4729
Иванец Н. Н. Николай Николаевич 1941-
Кинкулькина М. А. Марина Аркадьевна 1966-
Тартынский К. М. Кирилл Михайлович 1989-
Кренкель Г. Л. Галина Львовна 1976-
Ivanets N. N. Nikolay Nikolaevich 1941-
Kinkul`kina M. A. Marina Arkadyevna 1966-
Tarty'nskij K. M. Kirill Mikhaylovich 1989-
Krenkel` G. L. Galina L`vovna 1976-
The features of psychopharmacotherapy of depressive states with panic attacks
Текст визуальный непосредственный
Журнал неврологии и психиатрии им. C.C. Корсакова
Издательство Медиа Сфера
Т. 118, Вып. 4 С. 65-69
2018
Статья
Antidepressants Antipsychotics Anxiety disorders Bipolar affective disorder Depression Mood stabilizers Neurotic depression Panic attacks Psychopharmacotherapy Recurrent depressive disorder
antidepressant agent mood stabilizer tranquilizer neuroleptic agent adult anxiety Article bipolar disorder controlled study depression Hamilton Anxiety Scale human major clinical study Montgomery Asberg Depression Rating Scale panic psychopharmacotherapy adolescent middle aged psychological rating scale young adult Adolescent Adult Antidepressive Agents Antipsychotic Agents Anxiety Humans Middle Aged Panic Disorder Psychiatric Status Rating Scales Young Adult
Objective. To develop therapeutic programs for treatment of depression with panic attacks on the basis of their clinical and psychopathological features. Material and methods. A total of 100 in-and outpatients, aged from 18 to 60 years, with depression of mild and moderate severity with panic attacks were studied. The investigation was carried out using clinical, psychopathological and psychometric (the Atypical Depression Diagnostic Scale (ADDS), the Montgomery—Asberg Depression Rating Scales (MADRS), and the Sheehan Anxiety Rating Scale (ShARS)) methods. The patients were assessed on admission, on the 1st, 2nd, 4th and 8th weeks with subsequent processing and defining standard indicators. Three therapeutic groups were formed: the 1st group received therapy combining an antidepressant and a tranquilizer; the 2nd group an antidepressant, a tranquilizer and a mood stabilizer; and the 3rd group an antidepressant, a tranquilizer and an antipsychotic agent. The time course of expression of